Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

November 30, 2022

https://www.globenewswire.com/news-release/2022/11/30/2564822/0/en/Renalytix-Reports-Financial-Results-for-First-Quarter-of-Fiscal-Year-2023.html

LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ:RNLX) (LSE:RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal first quarter ended September 30, 2022.

Read more at globenewswire.com

Related news for (RNLX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.